Article info

Download PDFPDF

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Authors

  1. j frank.jaschinski{at}secarna.com
  2. k alfred.zippelius{at}usb.ch
View Full Text

Citation

Kashyap AS, Thelemann T, Klar R, et al
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Publication history

  • Received November 19, 2018
  • Accepted February 22, 2019
  • First published March 12, 2019.
Online issue publication 
March 12, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.